tm logo

Monitor this mark

View On USPTO

EYLONGIR
Live/Pending
THIRD EXTENSION - GRANTED

granted

on 29 May 2024

Last Applicant/ Owned by

Regeneron Pharmaceuticals, Inc.

777 Old Saw Mill River Road

Tarrytown

NY

10591

Serial Number

97260195 filed on 09th Feb 2022

Registration Number

N/A

Correspondent Address

Terrence J. McAllister

Terrence J. McAllister Ruggiero McAllister & McMahon LLC

STAMFORD, CT 06901

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

EYLONGIR

Pharmaceutical preparations for the treatment of ophthalmological diseases and disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of ophthalmological diseases and disorders

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97260195

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 554.1828UST1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
13th Dec 2024SOU TEAS EXTENSION RECEIVED
30th May 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29th May 2024SOU EXTENSION 3 GRANTED
29th May 2024SOU EXTENSION 3 FILED
29th May 2024SOU TEAS EXTENSION RECEIVED
30th Jan 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
27th Jan 2024SOU EXTENSION 2 GRANTED
04th Jan 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
14th Dec 2023SOU TEAS EXTENSION RECEIVED
14th Dec 2023SOU EXTENSION 2 FILED